UNLABELLED: To increase the target-to-background ratio in receptor scintigraphy, we hypothesized that receptor scintigraphy is best performed using the lowest possible mass with the highest possible specific radioactivity of the radioligand. METHODS: Rats were injected with 2 or 10 micrograms of unlabeled octreotide or 2 or 10 micrograms of 111In-pentetreotide. Scintigraphic images were then obtained from 10 min before to 20 min after the 111In injection. RESULTS: In some instances, there was a significant increase in 111In uptake in somatostatin receptor-positive organs. In others, there was a significant decrease. Since no significant differences were found in background radioactivity in the percent dose uptake of 111In in receptor-negative organs, these data indicate that target-to-background ratios can be increased by the administration of nonradiolabeled peptides under select conditions. CONCLUSION: The uptake of 111In-pentetreotide in somatostatin receptor-positive organs results in a tissue-specific bell-shaped function of the injected mass of the radiopharmaceutical. This curve may also apply to somatostatin receptor-positive tumors, the visualization of which may be enhanced by optimizing the mass of 111In-pentetreotide.
UNLABELLED: To increase the target-to-background ratio in receptor scintigraphy, we hypothesized that receptor scintigraphy is best performed using the lowest possible mass with the highest possible specific radioactivity of the radioligand. METHODS:Rats were injected with 2 or 10 micrograms of unlabeled octreotide or 2 or 10 micrograms of 111In-pentetreotide. Scintigraphic images were then obtained from 10 min before to 20 min after the 111In injection. RESULTS: In some instances, there was a significant increase in 111In uptake in somatostatin receptor-positive organs. In others, there was a significant decrease. Since no significant differences were found in background radioactivity in the percent dose uptake of 111In in receptor-negative organs, these data indicate that target-to-background ratios can be increased by the administration of nonradiolabeled peptides under select conditions. CONCLUSION: The uptake of 111In-pentetreotide in somatostatin receptor-positive organs results in a tissue-specific bell-shaped function of the injected mass of the radiopharmaceutical. This curve may also apply to somatostatin receptor-positive tumors, the visualization of which may be enhanced by optimizing the mass of 111In-pentetreotide.
Authors: William M Rockey; Ling Huang; Kyle C Kloepping; Nicholas J Baumhover; Paloma H Giangrande; Michael K Schultz Journal: Bioorg Med Chem Date: 2011-05-14 Impact factor: 3.641
Authors: Heather L Kimmel; Jonathon A Nye; Ronald Voll; Jiyoung Mun; Jeffrey Stehouwer; Mark M Goodman; John R Votaw; F I Carroll; Leonard L Howell Journal: Synapse Date: 2012-03-16 Impact factor: 2.562
Authors: Maarten Brom; Lieke Joosten; Peter Laverman; Wim J G Oyen; Martin Béhé; Martin Gotthardt; Otto C Boerman Journal: Mol Imaging Date: 2011-04 Impact factor: 4.488
Authors: Vladimir Tolmachev; Helena Wållberg; Mattias Sandström; Monika Hansson; Anders Wennborg; Anna Orlova Journal: Eur J Nucl Med Mol Imaging Date: 2010-11-11 Impact factor: 9.236
Authors: Magdalena Malm; Nina Kronqvist; Hanna Lindberg; Lindvi Gudmundsdotter; Tarek Bass; Fredrik Y Frejd; Ingmarie Höidén-Guthenberg; Zohreh Varasteh; Anna Orlova; Vladimir Tolmachev; Stefan Ståhl; John Löfblom Journal: PLoS One Date: 2013-05-10 Impact factor: 3.240